Monocytosis is a powerful and independent predictor of inferior survival in primary myelofibrosis

Br J Haematol. 2018 Dec;183(5):835-838. doi: 10.1111/bjh.15061. Epub 2017 Dec 19.

Affiliations

¹ Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.
² Division ofHematopathology, Department of Laboratory Medicine, Mayo Clinic, Rochester, MN, USA.
³ Division ofCytogenetics, Department of Laboratory Medicine, Mayo Clinic, Rochester, MN, USA.

PMID: 29265333
DOI: 10.1111/bjh.15061

No abstract available

Keywords: monocyte; myeloproliferative; prognosis; prognostic; survival.

Publication types

Letter

MeSH terms

Adult
Aged
Aged, 80 and over
Disease Progression
Female
Humans
Leukocytosis / mortality*
Male
Middle Aged
Monocytes / pathology*
Primary Myelofibrosis / mortality*
Primary Myelofibrosis / pathology
Primary Myelofibrosis / therapy
Prognosis
Stem Cell Transplantation / methods
Stem Cell Transplantation / mortality
Transplantation, Homologous / methods
Transplantation, Homologous / mortality